THE ORPHAN RECEPTOR FAMILY RZR/ROR, MELATONIN AND 5-LIPOXYGENASE - AN UNEXPECTED RELATIONSHIP

被引:163
|
作者
CARLBERG, C [1 ]
WIESENBERG, I [1 ]
机构
[1] CIBA GEIGY AG, PHARMA FORSCH, CH-4002 BASEL, SWITZERLAND
关键词
NUCLEAR HORMONE RECEPTORS; LIGAND IDENTIFICATION; GENE REGULATION; NATURAL RESPONDING GENES; NUCLEAR SIGNALING OF MELATONIN;
D O I
10.1111/j.1600-079X.1995.tb00157.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The orphan receptors RZR alpha, RZR beta, ROR alpha 1, RZR alpha 2, ROR alpha 3, and ROR gamma form a subfamily within the superfamily of nuclear hormone receptors. Recently, experimental evidence that the pineal gland hormone melatonin is the natural ligand for these nuclear receptors has come to light. This discovery is rather surprising, given that most people in the field believed melatonin acts exclusively through membrane receptors. However, these new findings establish a nuclear signalling pathway for melatonin, i.e., direct ligand-induced control of target gene transcription, which most probably mediates part of the physiological functions of the hormone. Interestingly, the very recently identified first RZR/melatonin responding gene, 5-lipoxygenase, is not expressed in the brain and is not involved in circadian rhythmicity, but rather acts in the periphery, mainly in myeloid cells, as one of the key enzymes of allergic and inflammatory reactions. Thus, nuclear melatonin signalling opens up a new perspective in understanding the actions of the pineal gland hormone.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 50 条
  • [21] Increased hippocampal 5-lipoxygenase mRNA content in melatonin-deficient, pinealectomized rats
    Uz, T
    Longone, P
    Manev, H
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 (05) : 2220 - 2223
  • [22] QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP OF CATECHOL DERIVATIVES INHIBITING 5-LIPOXYGENASE
    NAITO, Y
    SUGIURA, M
    YAMAURA, Y
    FUKAYA, C
    YOKOYAMA, K
    NAKAGAWA, Y
    IKEDA, T
    SENDA, M
    FUJITA, T
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1991, 39 (07) : 1736 - 1745
  • [23] 5-Lipoxygenase polymorphism and in-vivo response to leukotriene receptor antagonists
    Stephen J. Fowler
    Ian P. Hall
    Andrew M. Wilson
    Amanda P. Wheatley
    Brian J. Lipworth
    European Journal of Clinical Pharmacology, 2002, 58 : 187 - 190
  • [24] 5-lipoxygenase polymorphism and in-vivo response to leukotriene receptor antagonists
    Fowler, SJ
    Hall, IP
    Wilson, AM
    Wheatley, AP
    Lipworth, BJ
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (03) : 187 - 190
  • [25] Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma
    Drazen, JM
    PHARMACOTHERAPY, 1997, 17 (01): : S22 - S30
  • [26] Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism
    Munoz, NM
    Douglas, I
    Mayer, D
    Herrnreiter, A
    Zhu, XD
    Leff, AR
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (04) : 1398 - 1403
  • [27] Melatonin Suppresses Activation of Hepatic Stellate Cells through RORα-mediated inhibition of 5-lipoxygenase.
    Shajari, Shiva
    Laliena, Almudena
    Heegsma, Janette
    Jesus Tunon, Maria
    Moshage, Han
    Faber, Klaas Nico
    HEPATOLOGY, 2015, 62 : 894A - 894A
  • [28] EVIDENCE FOR THE EXPRESSION OF A 5-LIPOXYGENASE MULTITRANSCRIPT FAMILY IN HUMAN BRAIN-TUMORS
    BOADO, RJ
    BLACK, KL
    PARDRIDGE, WM
    CLINICAL RESEARCH, 1993, 41 (01): : A52 - A52
  • [29] mRNA expression of nuclear receptor RZR/RORα, melatonin membrane receptor MT1, and hydroxindole-O-methyltransferase in different populations of human immune cells
    Pozo, D
    García-Mauriño, S
    Guerrero, JM
    Calvo, JR
    JOURNAL OF PINEAL RESEARCH, 2004, 37 (01) : 48 - 54
  • [30] Genetic determinants of 5-lipoxygenase pathway in a Spanish population and their relationship with cardiovascular risk
    Camacho, Mercedes
    Martinez-Perez, Angel
    Buil, Alfonso
    Siguero, Laura
    Alcolea, Sonia
    Lopez, Sonia
    Fontcuberta, Jordi
    Souto, Juan-Carlos
    Vila, Luis
    Soria, Jose-Manuel
    ATHEROSCLEROSIS, 2012, 224 (01) : 129 - 135